For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
KEY FINDINGS
There are various reasons for infertility, which include physiological, genetically induced disorders and at times may be self-induced as in the case of contraceptive surgeries. Infertility treatment is a multi-billion dollar industry. The key factors driving the market include raising awareness among couples about various infertility treatments, low-cost treatment options and an increase in new options for infertility treatment such as surrogacy.
The market is expected to lead throughout the forecast period of 2019-2027 by proliferating at a CAGR of 6.12%. The market is expected to lead throughout the forecast period of 2019-2027.
MARKET INSIGHTS
Medical tourism has been a key enabler for the growth of the infertility testing and treatment market. Fertility tourism for IVF, donor sperm, surrogate mothers and other infertility treatments are increasing due to a decrease in domestic supply and stringent government regulations in Europe.
The economies of the United Kingdom, Germany, France, Russia, and the Nordics are the major contributors to the market growth in Europe. The Nordic region has been a destination for fertility tourism for most couples from Europe, North America, Kenya, and Hong Kong. German infertility testing and treatment is the second fastest growing market in Europe. Increasing success rates of the IVF treatments within the region has led to significant growth in this market.
COMPETITIVE INSIGHTS
The major market players mentioned in the report are Vitrolife AB, Endo Pharmaceuticals, Merck, The Cooper Companies, Inc., Irvine Scientific, Genea, Thermo Fisher Scientific Inc., Quest Diagnostic, Ovascience, Halotech DNA, Origio, Andrology Solutions, Ferring Pharmaceuticals, Esco Micro PTE. Ltd., and Progyny.